These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 39004504)

  • 1. Correspondence on 'Technique and impact on first pass effect primary results of the ASSIST global registry' by Gupta
    Sacks D
    J Neurointerv Surg; 2024 Jul; ():. PubMed ID: 39004504
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to: Correspondence on 'Technique and impact on first pass effect primary results of the ASSIST global registry' by Gupta
    Gupta R
    J Neurointerv Surg; 2024 Jul; ():. PubMed ID: 38969495
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, shared decision-making and patient outcomes. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco
    Gianfrancesco M; Hyrich KL; Yazdany J; Machado PM; Robinson PC
    Ann Rheum Dis; 2022 Oct; 81(10):e191. PubMed ID: 32796043
    [No Abstract]   [Full Text] [Related]  

  • 4. Correspondence to: 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco
    Flood RM; Conway R; Kirby C; Gheta D; Kane DJ; Mullan RH
    Ann Rheum Dis; 2023 Jun; 82(6):e140. PubMed ID: 32816697
    [No Abstract]   [Full Text] [Related]  

  • 5. Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M
    Cacciapaglia F; Manfredi A; Erre G; Piga M; Sakellariou G; Viapiana O; Gremese E; Spinelli FR; Atzeni F; Bartoloni E
    Ann Rheum Dis; 2023 Jul; 82(7):e159. PubMed ID: 32933920
    [No Abstract]   [Full Text] [Related]  

  • 6. Rheumatic disease activity, glucocorticoid use and COVID-19. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco
    Hyrich KL; Gianfrancesco M; Machado PM; Yazdany J; Robinson PC
    Ann Rheum Dis; 2022 Nov; 81(11):e223. PubMed ID: 32895239
    [No Abstract]   [Full Text] [Related]  

  • 7. Correspondence on 'Clinical value of pre-operative scoring systems to predict leiomyosarcoma: results of a validation study in 177 patients from the NOGGO-REGSA Registry' by Condic
    Vollmer M; Köhler G
    Int J Gynecol Cancer; 2022 Jul; 32(7):963. PubMed ID: 35618309
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to: Correspondence on 'Clinical value of pre-operative scoring systems to predict leiomyosarcoma: results of a validation study in 177 patients from the NOGGO-REGSA Registry' by Vollmer
    Condic M; Staerk C; Mustea A
    Int J Gynecol Cancer; 2022 Jul; 32(7):964. PubMed ID: 35618310
    [No Abstract]   [Full Text] [Related]  

  • 9. Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco
    Giollo A; Bertoldo E; Adami G; Cybulski AJ; Fassio A; Orsolini G; Idolazzi L; Gatti D; Viapiana O; Rossini M
    Ann Rheum Dis; 2022 Nov; 81(11):e222. PubMed ID: 32895237
    [No Abstract]   [Full Text] [Related]  

  • 10. Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco
    Khan A; Cole A; Bhadauria N; El-Hassan M; Abdulla D; Axon T; Fattah Z; Manson JJ; Moreno-Cuesta J; Mukerjee D
    Ann Rheum Dis; 2022 Oct; 81(10):e188. PubMed ID: 32732244
    [No Abstract]   [Full Text] [Related]  

  • 11. Technique and impact on first pass effect primary results of the ASSIST global registry.
    Gupta R; Miralbés S; Calleja Bonilla A; Naravetla B; Majjhoo AQ; Rayes M; Spiotta AM; Loehr C; Cioltan A; Vollherbst DF; Martínez-Galdámez M; Galván-Fernandez J; Khaldi A; McTaggart RA; Jayaraman MV; Defreyne L; Dhondt E; Vega P; Murias E; Lin E; Chaubal V; Price LL; Liebeskind DS; Möhlenbruch MA;
    J Neurointerv Surg; 2024 Jan; ():. PubMed ID: 38195248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry'.
    Mulhearn B
    Ann Rheum Dis; 2023 May; 82(5):e115. PubMed ID: 33648958
    [No Abstract]   [Full Text] [Related]  

  • 13. Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry'.
    Arnaud L; Devilliers H
    Ann Rheum Dis; 2023 May; 82(5):e113. PubMed ID: 33602796
    [No Abstract]   [Full Text] [Related]  

  • 14. Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry'.
    Rosenbaum JT; Weisman MH; Shafer C; Aslanyan E; Howard RA; Ogle K; Hamilton H; Reveille JD; Winthrop KL; Choi D
    Ann Rheum Dis; 2023 Jun; 82(6):e138. PubMed ID: 33985940
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry' by Arnaud and Devilliers.
    Machado PM; Schäfer M; Strangfeld A; Gossec L; Gianfrancesco M; Lawson-Tovey S; Mateus EF; Carmona L; Hyrich KL; Robinson PC; Yazdany J
    Ann Rheum Dis; 2023 May; 82(5):e114. PubMed ID: 33602795
    [No Abstract]   [Full Text] [Related]  

  • 16. Comment on: 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco
    Karahan S; Cetinkaya A; Aydin K; Aslan Sirakaya H
    Ann Rheum Dis; 2023 Mar; 82(3):e75. PubMed ID: 32719043
    [No Abstract]   [Full Text] [Related]  

  • 17. Comment on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M
    Andreica I; Kiefer D; Rezniczek GA; Jast R; Buehring B; Kiltz U; Baraliakos X; Braun J
    Ann Rheum Dis; 2022 Oct; 81(10):e189. PubMed ID: 32732243
    [No Abstract]   [Full Text] [Related]  

  • 18. Checkpoint inhibitors: the new treatment paradigm for urothelial bladder cancer.
    Katz H; Wassie E; Alsharedi M
    Med Oncol; 2017 Sep; 34(10):170. PubMed ID: 28864844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to Barraclough et al. on 'degree-of-spread artefact in the NSW Central Cancer Registry'.
    Yu XQ; O'Connell D; Armstrong B
    Aust N Z J Public Health; 2009 Feb; 33(1):95-6. PubMed ID: 19236369
    [No Abstract]   [Full Text] [Related]  

  • 20. Correspondence to the article 'risk of urinary tract infection in patients with hydroureter: an analysis from the society of fetal urology prenatal hydronephrosis registry'.
    Agrawal T; Tk J; Rathod K; Pathak M; Sinha A
    J Pediatr Urol; 2022 Oct; 18(5):722-723. PubMed ID: 36008201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.